Mertabto 50mg Tablet
Marketer
Emcure Pharmaceuticals Ltd
Salt Composition
Mercaptopurine (50mg)
Overview Mertabto 50mg Tablet
Myelostat 50mg tablets are indicated in the management of hematologic malignancies. Its mechanism involves reducing red blood cell production, thereby hindering cancerous cell proliferation. Myelostat 50mg tablets may be administered with or without food, or one hour prior to, or two hours after, a meal. Dosage and frequency are determined by your physician, dependent on your specific condition and subject to adjustment. Adhere strictly to your prescribed regimen; incorrect usage or overdose can lead to severe adverse reactions. Therapeutic benefits may not be evident for several weeks or months; discontinue only under medical supervision. Common side effects include nausea, emesis, dermatological reactions, diarrhea, and anorexia. This medication can lower blood cell counts (including red and white blood cells), increasing infection vulnerability. Regular blood tests monitoring blood cell levels, cardiac function, hepatic function, and uric acid are necessary. Refrain from driving or activities requiring alertness if dizziness occurs. Inform your physician of any pre-existing cardiac, hepatic, or renal conditions, or concurrent use of antimicrobial agents, before commencing treatment. Numerous drug interactions are possible; disclose all medications to your doctor. This medication is contraindicated during pregnancy and lactation. Reliable contraception is essential for both partners throughout the treatment period to prevent conception.
Uses of Mertabto 50mg Tablet
Hematological malignancy
Major Benefits of Mertabto 50mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the 50mg Mertabto tablet whole; avoid chewing, crushing, or fracturing it. Consumption may coincide with meals or be taken independently, although consistent timing is recommended.
Common Side effects of Mertabto 50mg Tablet:
- Nausea
- Vomiting
- Rash
- Decreased white blood cell count (neutrophils)
- Intestinal ulcer
- Anemia (low number of red blood cells)
- Increased bilirubin in the blood
- Low blood platelets
- Increased transaminase level in blood
- Diarrhea
- Loss of appetite
How to use Mertabto 50mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 50mg Mertabto tablet whole; avoid chewing, crushing, or breaking it. While it can be taken with or without food, consistent timing is recommended.
How Mertabto 50mg Tablet works:
Mertabto 50mg tablets disrupt cancer cell proliferation by replacing essential DNA and RNA components, thus halting their growth and replication.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Mertabto 50mg Tablets may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Using Mertabto 50mg tablets during pregnancy poses a confirmed risk to the fetus. Therefore, its use is contraindicated. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential advantages outweigh the known hazards. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Using Mertabto 50mg tablets while breastfeeding is likely inadvisable. Available evidence from humans indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Mertabto 50mg Tablets.
KidneyCAUTION
Individuals with kidney impairment should exercise caution when using Mertabto 50mg tablets. Dosage modification may be necessary. Physician consultation is recommended.
LiverCAUTION
Patients with hepatic impairment should exercise caution when using Mertabto 50mg tablets, as dosage modification may be necessary. Physician consultation is recommended. Report any symptoms indicative of jaundice to your doctor during treatment.
What if you forget to take Mertabto 50mg Tablet :
NA
Facts to Know About Mertabto 50mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Thiopurines |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Actions | Metabolic inhibitors |
3,018 People bought this recently